I believe in “informed intercession.” In other words, there is power when you comprehend a topic or matter and pray with greater understanding. We have made that a prevailing practice of Bound4LIFE.
As we continue to press forward in the challenge against the abortion pill, my aim is to raise up prayer and intercession with a vital level of insight—fully grasping the immense problem and tremendous opportunity we now face.
I want to encourage and exhort you to inform yourself on these matters. It is essential that we hit the mark in our prayers to see history shift and the tragic storyline of the abortion pill change in America.
UNDERSTANDING THE CASE
Two weeks after the landmark Dobbs case was heard at the U.S. Supreme Court in December 2021, the Biden FDA announced a policy of nonenforcement of the in-person dispensing requirement for the abortion pill.
Something insidious was being set in motion.
Roe v. Wade was overturned in June 2022, but the FDA formally eliminated the in-person dispensing requirement in January 2023—an evil parting gift of the most pro-abortion administration in history.
That set the stage for legal challenges that are working their way through the courts right now.
LOUISIANA v. FDA
In focus is Louisiana’s case challenging the FDA’s actions. Louisiana argues, among other things, that the FDA acted unlawfully under the Administrative Procedure Act when it removed the in-person dispensing requirement. On April 7, 2026, the federal district court paused the case while the FDA conducted its ongoing review of mifepristone regulations.
Louisiana appealed that decision to the Fifth Circuit.
On May 1, 2026, the Fifth Circuit granted Louisiana interim relief, suspending the FDA’s 2023 changes while the appeal proceeded. In practical terms, that would have restored the in-person dispensing requirement for mifepristone during the litigation. The Fifth Circuit concluded that Louisiana had made a strong argument that the FDA’s action was arbitrary and capricious.
Two manufacturers of mifepristone—Danco Laboratories and GenBioPro—then intervened and asked the U.S. Supreme Court to block the Fifth Circuit’s order.
On May 14, 2026, the Supreme Court granted the manufacturers’ request for a “stay.” That means the Court put the Fifth Circuit’s ruling on hold, allowing the current dispensing rules to remain in effect while the Fifth Circuit hears the appeal.
DISSENTING COMMENTS
It’s important to understand that when SCOTUS granted the stay, the Court did not issue a ruling on the merits of the underlying case. The order temporarily blocked the Fifth Circuit’s ruling while the appeal continues.
Justices Thomas and Alito dissented. They would have allowed the Fifth Circuit’s order to take effect. Both wrote separately to explain their views, making significant comments about the legal issues surrounding this case. Their dissents also reveal arguments that will become important when the dispute eventually reaches the Supreme Court.
Justice Thomas wrote about the manufacturers of the abortion pill:
They complain that the Fifth Circuit’s order would reduce profits they derive from selling mifepristone. It is a criminal offense to ship mifepristone for use in abortions. The Comstock Act bans using “the mails” to ship any “drug . . . for producing abortion.” A neighboring provision makes it a felony to use “any express company or other common carrier or interactive computer service” to ship “any drug . . . designed, adapted, or intended for producing abortion.” As relevant to this case, mifepristone shipped to Louisiana, which bans abortion, causes nearly 1,000 abortions per month. “All of this violates the Comstock Act.”
Thomas goes on:
Applicants are not entitled to a stay of an adverse court order based on lost profits from their criminal enterprise. They cannot, in any legally relevant sense, be irreparably harmed by a court order that makes it more difficult for them to commit crimes.
Justice Alito rightly discerned the situation:
The Court’s unreasoned order granting stays in this case is remarkable. What is at stake is the perpetration of a scheme to undermine our decision in Dobbs v. Jackson Women’s Health Organization, which restored the right of each State to decide how to regulate abortions within its borders. This scheme would not have been possible under FDA regulations had the Federal Government not taken steps in 2021 and 2023 to facilitate mail-order abortions.
These scathing rebukes are well-earned.
But understanding what is happening is not enough. We are not simply following a court case or watching a legal battle unfold from the sidelines. This is precisely why informed intercession matters. When the issues become clear, our prayers can become clear. We can identify what is at stake, where the battle lines have been drawn, and how to pray with precision.
I want to introduce you to a discipline we have adopted in other similar situations. I have found it strategic and effective to take the words of legal dissent in cases like this and turn them into actual prayers.
I will demonstrate that with today’s prayer points.
PRAYER POINTS
The Comstock Act has been federal law since 1873. Pray for the Trump administration, Attorney General Todd Blanche, and the Department of Justice to enforce the Comstock Act.
Pray that manufacturers of the abortion pill will not be allowed to commit felonious crimes.
Pray that the scheme to undermine the Dobbs decision will be exposed and stopped.
Please continue to pray for HHS Secretary Robert F. Kennedy Jr. and the FDA’s ongoing investigation of mifepristone.
